Nns Clinical Research LLC is categorized under Neurological Laboratory in Tucson, AZ and active since 2012.
Nns Clinical Research LLC was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Neurological Laboratory business, which does work in the B2C market, and is classified as a Neurological Laboratory, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact David Anthony Weidman at the company’s single location by writing to 5910 North La Cholla Boulevard, Tucson, Arizona AZ 85741 or by phoning (520) 742-7890. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nns Clinical Research LLC |
| Contact Person: | David Anthony Weidman |
| Address: | 5910 North La Cholla Boulevard, Tucson, Arizona 85741 |
| Phone Number: | (520) 742-7890 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Neurological Laboratory |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Nns Clinical Research LLC was started in 2012 to provide professional Neurological Laboratory under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Anthony Weidman for inquiries that concern Nns Clinical Research LLC by calling the company number (520) 742-7890, as your correspondence is most welcome. Additionally, the physical location of the single location of Nns Clinical Research LLC can be found at the coordinates 32.313975,-111.011893 as well as the street address 5910 North La Cholla Boulevard in Tucson, Arizona 85741.
For its online presence, you may visit Nns Clinical Research LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.